Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Church who wrote (1110)	7/31/1997 11:25:00 PM
From: JOHN W.	of 6136

My work is done as far as Viracept, it has proven itself. It is ridiculous that this thread is so short sighted that this cancer drug discovery platform is widely recognized as the nelf Co. We have been looking at this one tree and have ignored the forrest (the street has done this too). Meanwhile, there will be this grand recognition on the Cancer front in the next 8 months: -AG 2034 phase I results before X-mas. -THYMITAQ NDA Mar-Apr 98. -How cheap will this stock look with the continuing positive results of AG 3340. -W W Sales of THYMITAQ (2000E): $60M-90M. "Before you take profits this year, research AG 3340, AG2034, and Thymitaq-stay along for the ride" my source.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next